Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Tag Archives: Pharma
Nothing is Rotten in the State of Denmark
Guest blog by Reflector, Pharm Exec Europe’s Brussels correspondent.
Denmark is still on the fringes of some European Union policies. Notably, it has not yet embraced the euro as a currency, and it keeps its distance from the common defence policy. But in one respect, its pharmaceutical industry has just shown that it is well abreast [...]
Posted in Europe, Global, Guest Blog, Regulatory Also tagged code of practice, Denmark, Europe, European Commission, European Union, LIF, transparency Leave a comment
Europe: Of Apes and Ombudsmen
Guest blog by Reflector, Pharm Exec Europe’s Brussels correspondent.
This column has frequently drawn attention to the complexities of getting anything done in Europe. A brilliant researcher can explore visionary horizons, an ambitious entrepreneur can offer a package of goods or services of inestimable value, but the degree of control and regulation becomes more intense [...]
Posted in Europe, Global, Regulatory Also tagged animal research, animal rights activism, European Commission, European Ombudsman, European Union Leave a comment
Pharma and Haiti: Can Altruism Backfire?
Guest blog by Pharm Exec Europe’s Jacky Law.
Pharma companies are responding swiftly to the recent earthquake in Haiti with millions of dollars in cash and drugs. GlaxoSmithKline boasted, for example, that its initial $1.2 million offering of medicines — mainly oral and topical antibiotics — was on the first airlift to the Caribbean island and [...]
Posted in Corporate Responsibility, Global, Guest Blog, News Also tagged Big Pharma, corporate social responsibility, donations, Haiti, Johnson & Johnson Leave a comment
Connect with a Click of the Mouse
Thanks to Google, Facebook, and Twitter, the Internet has become the e-Patient’s No. 1 destination for seeking health information, and industry was all “a tweet” about it at this year’s e-Patient Connections Conference.
More than 250 people were in attendance for the two-day event, which included pharma marketers, brand managers, and patient education specialists who shared [...]
Posted in E-Media, Events Also tagged e-Patient Connections Conference, Facebook, Google, Health care, Marketing, Marketing strategy, Online Communities, Social network, Twitter Leave a comment

Patients Want to Talk. Do You?